Vanguard Group’s PharmaCyte Biotech PMCB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
194,447
-71
| -0% | -$78 | ﹤0.01% | 4080 |
|
|
2025
Q1 | $243K | Buy |
194,518
+2,131
| +1% | +$2.66K | ﹤0.01% | 4031 |
|
|
2024
Q4 | $298K | Hold |
192,387
| – | – | ﹤0.01% | 4041 |
|
|
2024
Q3 | $367K | Hold |
192,387
| – | – | ﹤0.01% | 4044 |
|
|
2024
Q2 | $377K | Buy |
192,387
+17,785
| +10% | +$34.9K | ﹤0.01% | 4068 |
|
|
2024
Q1 | $414K | Buy |
174,602
+3,267
| +2% | +$7.74K | ﹤0.01% | 4062 |
|
|
2023
Q4 | $370K | Buy |
171,335
+2,414
| +1% | +$5.21K | ﹤0.01% | 4116 |
|
|
2023
Q3 | $355K | Sell |
168,921
-14,661
| -8% | -$30.8K | ﹤0.01% | 4151 |
|
|
2023
Q2 | $525K | Sell |
183,582
-517,868
| -74% | -$1.48M | ﹤0.01% | 4110 |
|
|
2023
Q1 | $2.04M | Buy |
701,450
+46,933
| +7% | +$137K | ﹤0.01% | 3664 |
|
|
2022
Q4 | $1.92M | Buy |
654,517
+11,343
| +2% | +$33.2K | ﹤0.01% | 3669 |
|
|
2022
Q3 | $1.54M | Buy |
643,174
+800
| +0.1% | +$1.92K | ﹤0.01% | 3853 |
|
|
2022
Q2 | $1.44M | Buy |
642,374
+27,749
| +5% | +$62.2K | ﹤0.01% | 3955 |
|
|
2022
Q1 | $1.41M | Buy |
614,625
+959
| +0.2% | +$2.21K | ﹤0.01% | 4096 |
|
|
2021
Q4 | $1.53M | Buy |
+613,666
| New | +$1.53M | ﹤0.01% | 4133 |
|